These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36196692)

  • 41. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
    Woo JH; Kim EC; Kim SM
    Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Explainable Artificial Intelligence in Ambulatory Digital Dementia Screenings.
    Schinle M; Erler C; Hess M; Stork W
    Stud Health Technol Inform; 2022 May; 294():123-124. PubMed ID: 35612031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Digital therapeutics and clinical pharmacology.
    Chung JY
    Transl Clin Pharmacol; 2019 Mar; 27(1):6-11. PubMed ID: 32055575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of artificial intelligence clinical applications: Detailed case analyses show value of healthcare ethics approach in identifying patient care issues.
    Rogers WA; Draper H; Carter SM
    Bioethics; 2021 Sep; 35(7):623-633. PubMed ID: 34046918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging Artificial Intelligence-Empowered mHealth: Scoping Review.
    Bhatt P; Liu J; Gong Y; Wang J; Guo Y
    JMIR Mhealth Uhealth; 2022 Jun; 10(6):e35053. PubMed ID: 35679107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethics, Integrity, and Retributions of Digital Detection Surveillance Systems for Infectious Diseases: Systematic Literature Review.
    Zhao IY; Ma YX; Yu MWC; Liu J; Dong WN; Pang Q; Lu XQ; Molassiotis A; Holroyd E; Wong CWW
    J Med Internet Res; 2021 Oct; 23(10):e32328. PubMed ID: 34543228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study.
    Huang PH; Kim KH; Schermer M
    J Med Internet Res; 2022 Jan; 24(1):e33081. PubMed ID: 35099399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial.
    Li Y; Gong Y; Zheng B; Fan F; Yi T; Zheng Y; He P; Fang J; Jia J; Zhu Q; Jiang J; Huo Y
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e32251. PubMed ID: 34906924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Category and Use Cases on Digital Therapeutic Methodologies.
    An S; Ko J; Yu KS; Kwon H; Kim S; Hong J; Kong HJ
    Healthc Inform Res; 2023 Jul; 29(3):190-198. PubMed ID: 37591674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to Adoption of Digital Therapeutics (DTx) into Audiology Clinical Practice: Acknowledging the Challenges, Adapting to the Future.
    Roberts MJ; Wilson WJ; Recugnat M; Bardy F
    Semin Hear; 2023 Aug; 44(3):319-327. PubMed ID: 37484989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology.
    Ribba B; Peck R; Hutchinson L; Bousnina I; Motti D
    Clin Pharmacol Ther; 2023 Sep; 114(3):578-590. PubMed ID: 37392464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apprehensions about Excessive Belief in Digital Therapeutics: Points of Concern Excluding Merits.
    Kim HS
    J Korean Med Sci; 2020 Nov; 35(45):e373. PubMed ID: 33230984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential value and impact of data mining and machine learning in clinical diagnostics.
    Saberi-Karimian M; Khorasanchi Z; Ghazizadeh H; Tayefi M; Saffar S; Ferns GA; Ghayour-Mobarhan M
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):275-296. PubMed ID: 33739235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.
    Pashkov VM; Harkusha AO; Harkusha YO
    Wiad Lek; 2020; 73(12 cz 2):2722-2727. PubMed ID: 33611272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas.
    Denecke K; May R; Gabarron E; Lopez-Campos GH
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks.
    Yan K; Balijepalli C; Druyts E
    Front Digit Health; 2021; 3():667016. PubMed ID: 34713140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
    Diabetologia; 2020 Feb; 63(2):229-241. PubMed ID: 31802144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artificial Intelligence in Healthcare and Medicine: Promises, Ethical Challenges and Governance.
    Guan J
    Chin Med Sci J; 2019 Jun; 34(2):76-83. PubMed ID: 31315747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digital therapeutics from bench to bedside.
    Wang C; Lee C; Shin H
    NPJ Digit Med; 2023 Mar; 6(1):38. PubMed ID: 36899073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping research strands of ethics of artificial intelligence in healthcare: A bibliometric and content analysis.
    Saheb T; Saheb T; Carpenter DO
    Comput Biol Med; 2021 Aug; 135():104660. PubMed ID: 34346319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.